RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jeffrey Shy

Neurology · Mesa, AZNPI 1831246503

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 350 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 50 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2021 is the largest year on record at $3,060, more than ten times the $202 reported in 2019.

$5,902in general payments, 2019–2025

Across 350 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$935
  • Amgen$698
  • Biogen$419
  • UCB, Inc.$337
  • Upsher-smith Laboratories LLC$265
  • Supernus Pharmaceuticals, Inc.$233
  • plus $3K from 44 others
$47,296in research payments, 2019–2025

Across 33 payments — averaging $1433.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$29K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$16K
  • Merck$3K

What the payments were for

  • Speaking & faculty fees$711%
  • Food & beverage$5,79198%
  • Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)52$935
Amgen(2 entities)35$698
Biogen34$419
UCB, Inc.25$337
Upsher-smith Laboratories LLC20$265
Supernus Pharmaceuticals, Inc.28$233
CSL Behring10$224
Sunovion Pharmaceuticals Inc.13$218
Lilly USA, LLC13$189
MDD US Operations, LLC3$175
AstraZeneca8$175
Biohaven Pharmaceuticals, Inc.9$148
Acadia Pharmaceuticals Inc6$124
EMD Serono, Inc.5$114
Novartis6$107
Johnson & Johnson7$105
Harmony Biosciences LLC5$98
Amneal Pharmaceuticals LLC6$95
Sanofi4$90
SK Life Science, Inc.4$85
Bristol Myers Squibb4$81
Eisai Inc.4$74
Acorda Therapeutics, Inc4$71
Medtronic(2 entities)4$60
Banner Life Sciences, LLC1$60
Abbott3$57
Teva Pharmaceuticals USA, Inc.4$54
Tanabe Pharma America, Inc.2$50
Genentech USA, Inc.2$45
Lundbeck LLC2$44
Strongbridge US Inc.2$38
Neurocrine Biosciences, Inc.2$38
E.r. Squibb & Sons, L.L.C.2$37
Almatica Pharma LLC3$36
Grifols USA, LLC2$34
Mallinckrodt Hospital Products Inc.1$33
Arbor Pharmaceuticals, Inc.2$29
Kyowa Kirin, Inc.1$26
Covidien LP1$22
Vanda Pharmaceuticals Inc.1$21
Otto Bock Healthcare LP1$18
Penumbra, Inc.1$18
Merck1$18
Livanova USA, Inc.1$17
Collegium Pharmaceutical, Inc.1$16
Boston Scientific1$15
GRT US Holding, Inc.1$15
Neurelis, Inc.1$15
Avanir Pharmaceuticals, Inc.1$13
Zyla Life Sciences, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,902 in reported general payments places this provider in the 65th percentile of 388 neurology providers in Arizona.

See all neurology providers in Arizona →

Other neurology in Mesa

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →